Lv7
4992 积分 2025-08-08 加入
Preclinical development of MGC028, an ADAM9-targeted, glycan-linked, exatecan-based antibody-drug conjugate for the treatment of solid cancers
4个月前
已完结
NAD+ Hydrolysis Catalyzed by SelO is Required for Mitochondrial Homeostasis
5个月前
已完结
Amniogenesis in embryos and stem cell models
5个月前
已完结
Temporal proteomic and phosphoproteomic dynamics during neuronal differentiation in the reference iPSC line KOLF2.1J
5个月前
已完结
Immunity in Alzheimer’s disease: From mechanisms to therapies
6个月前
已完结
Lysosomes as hubs of metabolic sensing and cellular homeostasis
6个月前
已完结
Stretched to meet the challenge of myelination
6个月前
已完结
The evolution of gene regulation in mammalian cerebellum development
6个月前
已完结
Peripheral cancer attenuates amyloid pathology in Alzheimer’s disease via cystatin-c activation of TREM2
7个月前
已完结
Meeting the need for myelin
7个月前
已完结
Chitosan-Hyaluronic Acid Composite Hydrogel with Slow-Release Hydrogen Sulfide and Cerium Oxide for Multifunctional Synergy to Promote Healing of Infected Wounds
5个月前
已采纳
NAD+ Hydrolysis Catalyzed by SelO is Required for Mitochondrial Homeostasis
5个月前
已采纳
NAD+ Hydrolysis Catalyzed by SelO is Required for Mitochondrial Homeostasis
5个月前
已采纳
NAD+ Hydrolysis Catalyzed by SelO is Required for Mitochondrial Homeostasis
5个月前
已采纳
NAD+ Hydrolysis Catalyzed by SelO is Required for Mitochondrial Homeostasis
5个月前
已采纳
Suppressing Endothelial–Mesenchymal Transition Through the Histone Deacetylase 1/GATA Binding Protein 4 Pathway: The Mechanism of Protocatechuic Acid Against Myocardial Fibrosis Revealed by an Integrated Study
5个月前
已采纳
Cardiomyocyte-derived HSPB1 regulates TGF-β1 maturation and inhibits endothelial-to-mesenchymal transition in myocardial fibrosis
5个月前
已采纳
From Chemical Curiosities and Trophy Molecules to Uranium-Based Catalysis: Developments for Uranium Catalysis as a New Facet in Molecular Uranium Chemistry
5个月前
已采纳
Engineered Geomedia Kaolin Clay-Reduced Graphene Oxide–Polymer Composite for the Remediation of Olaquindox from Water
6个月前
已采纳
Abstract B201: A phase 1 dose-finding study of X4P-001 (an oral CXCR4 inhibitor) and axitinib in patients with advanced renal cell carcinoma (RCC)
6个月前
已采纳
皖公网安备34019202002308
